A Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM).
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone; Doxorubicin liposomal; Vincristine
- Indications Multiple myeloma
- Focus Adverse reactions
- 18 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Dec 2006 Status change
- 23 Aug 2005 New trial record.